Key result
Higher neutrophil-to-lymphocyte ratio linked to ~27% greater vascular event risk in type 2 diabetes.
Why the study?
The relationship of neutrophil-to-lymphocyte ratio with cardiovascular events and all-cause mortality in type 2 diabetes patients, independent of C-reactive protein, was not quantified.
Does higher neutrophil-to-lymphocyte ratio predict vascular events and all-cause mortality in patients with type 2 diabetes?
Cohort (n=1,239)
Does higher neutrophil-to-lymphocyte ratio predict vascular events and all-cause mortality in patients with type 2 diabetes?
In patients with type 2 diabetes, higher neutrophil-to-lymphocyte ratio is associated with an increased risk of cardiovascular events and all-cause mortality, independent of C-reactive protein levels.
AIM: To quantify the relationship of neutrophil-to-lymphocyte ratio (NLR) with cardiovascular events and all-cause mortality in patients with type 2 diabetes (T2D), independent of C-reactive protein (CRP). METHODS: Patients with T2D from the UCC-SMART-cohort were studied using multivariable-adjusted Cox regression. The relationship of NLR and CRP with vascular events (cerebrovascular events, myocardial infarction and vascular death) and all-cause mortality was quantified. RESULTS: During 10,833 person-years, 232 vascular events and 302 deaths occurred in 1,239 patients with T2D. Risk of vascular events and all-cause mortality increased per standard deviation (SD) in NLR (hazard ratio (HR) 1.27; 95 % confidence interval (CI):1.11-1.46) and 1.15; 95 % CI:1.02-1.30) after adjustment for CRP. CRP was not associated with vascular events after adjustment for NLR, (HR per SD 1.03; 95 % CI: 0.90-1.19), but was associated with all-cause mortality (HR per SD 1.18; 95 % CI: 1.04-1.33). Notably, NLR was related to vascular events in patients with CRP < 2 mg/L (HR per unit 1.45; 95 % CI: 1.19-1.77). CONCLUSION: In patients with T2D, NLR is related to higher risk of CVD and all-cause mortality, independently from CRP. NLR is related to CVD even when CRP is low, indicating that NLR is a marker of CVD-risk in addition to CRP. Both NLR and CRP are independently related to all-cause mortality in T2D patients.
No takes yet. Share an insight, caveat, or question.
Hoes et al. (2024) conducted a cohort in Type 2 diabetes (n=1,239). Neutrophil-to-lymphocyte ratio (NLR) was evaluated on Vascular events (cerebrovascular events, myocardial infarction and vascular death) (HR 1.27, 95% CI 1.11-1.46). In patients with type 2 diabetes, a higher neutrophil-to-lymphocyte ratio was associated with an increased risk of vascular events (HR 1.27; 95% CI 1.11-1.46) independent of C-reactive protein.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: